Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

IMPORTANCE: Targeting oncogenic drivers (genomic alterations critical to cancer development and maintenance) has transformed the care of patients with lung adenocarcinomas. The Lung Cancer Mutation Consortium was formed to perform multiplexed assays testing adenocarcinomas of the lung for drivers in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kris, Mark G., Johnson, Bruce E., Berry, Lynne D., Kwiatkowski, David J., Iafrate, A. John, Wistuba, Ignacio I., Varella-Garcia, Marileila, Franklin, Wilbur A., Aronson, Samuel L., Su, Pei-Fang, Shyr, Yu, Camidge, D. Ross, Sequist, Lecia V., Glisson, Bonnie S., Khuri, Fadlo R., Garon, Edward B., Pao, William, Rudin, Charles, Schiller, Joan, Haura, Eric B., Socinski, Mark, Shirai, Keisuke, Chen, Heidi, Giaccone, Giuseppe, Ladanyi, Marc, Kugler, Kelly, Minna, John D., Bunn, Paul A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4163053/
https://ncbi.nlm.nih.gov/pubmed/24846037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2014.3741
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados